Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kandasamy Saravanan, Govindasamy Hunday & Poomani Kumaradhas. (2020) Binding and stability of indirubin-3-monoxime in the GSK3β enzyme: a molecular dynamics simulation and binding free energy study. Journal of Biomolecular Structure and Dynamics 38:4, pages 957-974.
Read now
Read now
Articles from other publishers (8)
Carlos S. M. B. Filho, Ramon R. P. P. B. de Menezes, Emanuel P. Magalhães, Yunierkis P. Castillo, Alice M. C. Martins & Damião P. de Sousa. (2023) Piplartine-Inspired 3,4,5-Trimethoxycinnamates: Trypanocidal, Mechanism of Action, and In Silico Evaluation. Molecules 28:11, pages 4512.
Crossref
Crossref
Hermann AM Mucke. (2021) Patent highlights June–July 2021. Pharmaceutical Patent Analyst 10:6, pages 237-244.
Crossref
Crossref
Aline A. Zuma & Wanderley de Souza. (2021) Chagas Disease Chemotherapy: What Do We Know So Far?. Current Pharmaceutical Design 27:38, pages 3963-3995.
Crossref
Crossref
Antonia Efstathiou & Despina Smirlis. (2021) Leishmania Protein Kinases: Important Regulators of the Parasite Life Cycle and Molecular Targets for Treating Leishmaniasis. Microorganisms 9:4, pages 691.
Crossref
Crossref
Bin Sun, Jiahao Wang, Luohua Liu, Longfei Mao, Lizeng Peng & Yuwei Wang. (2020) Synthesis and activity of novel indirubin derivatives. Chemical Biology & Drug Design 97:3, pages 565-571.
Crossref
Crossref
Rafael da Rosa, Eloir Paulo Schenkel & Lílian Sibelle Campos Bernardes. (2020) Semisynthetic and newly designed derivatives based on natural chemical scaffolds: moving beyond natural products to fight Trypanosoma cruzi. Phytochemistry Reviews 19:1, pages 105-122.
Crossref
Crossref
Antonia Efstathiou, Nicolas Gaboriaud-Kolar, Vassilios Myrianthopoulos, Konstantina Vougogiannopoulou, Ines Subota, Stephanie Aicher, Emmanuel Mikros, Philippe Bastin, Alexios-Leandros Skaltsounis, Ketty Soteriadou & Despina Smirlis. (2019)
Indirubin Analogues Inhibit
Trypanosoma brucei
Glycogen Synthase Kinase 3 Short and
T. brucei
Growth
. Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Crossref
Panagiota-Efstathia Nikolaou, Kerstin Boengler, Panagiotis Efentakis, Konstantina Vouvogiannopoulou, Anastasia Zoga, Nicholas Gaboriaud-Kolar, Vassilios Myrianthopoulos, Pavlos Alexakos, Nikolaos Kostomitsopoulos, Ioannis Rerras, Anna Tsantili-Kakoulidou, Alexios Leandros Skaltsounis, Andreas Papapetropoulos, Efstathios K Iliodromitis, Rainer Schulz & Ioanna Andreadou. (2019) Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors. Cardiovascular Research 115:7, pages 1228-1243.
Crossref
Crossref